• Explore /
  • Poster
  • / The efficacy and safety of transarterial chemoembolization combined with cadonilimab and lenvatinib for unresectable hepatocellular carcinoma: A phase II clinical trial.

The efficacy and safety of transarterial chemoembolization combined with cadonilimab and lenvatinib for unresectable hepatocellular carcinoma: A phase II clinical trial.

Abstract Poster

Authors

null

Guo Liang

Department of Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou, China

Guo Liang , Shanzhi Gu , Yabing Guo , Hailiang Li , Jingfeng Liu , Jibing Liu , Ming Huang , Yinghua Zou , Luke Huang , Yangyang Zhang , Ting Liu , Wei Liu , Zhongmin Wang , Baiyong Li , Yu Xia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05319431

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 478)

DOI

10.1200/JCO.2024.42.3_suppl.478

Abstract #

478

Poster Bd #

C3

Abstract Disclosures

Similar Posters

First Author: Xiang Nong

First Author: Tingbo Liang

First Author: Zhicheng Lai

First Author: Guoliang Shao